Read articles from Global

January 17, 2025 by telegraph.co.uk

To break a vaping addiction, strategies include tapering nicotine strength gradually, identifying triggers and seeking therapy, setting boundaries, using distractions like sweets, trying apps or text support interventions for quitting, and considering drug therapies like varenicline and cytisine. Progress can be hindered by triggers and a tendency to increase vaping frequency when reducing nicotine. Support from a buddy can aid in setting boundaries. It's crucial not to return to smoking cigarettes to avoid the unique risks they pose. Pharmacological therapies are available, but not yet licensed for vaping cessation in the UK, except for Nicorette’s QuickMist mouth spray.

January 17, 2025 by usatoday.com

The FDA authorized Zyn nicotine pouches, deeming them lower risk than cigarettes due to reduced harmful constituents. This decision contrasts with the proposed rule to slash nicotine levels in cigarettes. Critics, such as the Campaign for Tobacco-Free Kids, denounce the move, citing concerns about youth appeal and potential harm. Juul Labs settled with six states over false marketing claims targeting minors, while Philip Morris invests in Zyn production. Although the FDA warns against tobacco use, Zyn pouches offer a non-tobacco alternative. Nicotine in youth can harm brain functions, as stated by the CDC.

January 17, 2025 by reuters.com

The U.S. Food and Drug Administration (FDA) authorized the marketing of 20 Zyn nicotine pouch products, marking its first approval for this category. The FDA stated that these products pose lower cancer and health risks compared to cigarettes and smokeless tobacco due to reduced harmful constituents. However, Yolonda Richardson, CEO of the Campaign for Tobacco-Free Kids, criticized the decision, arguing that flavored products like citrus and peppermint appeal to youth. She warned that the FDA's move risks increasing youth use of nicotine pouches, drawing parallels to the rise of Juul.

January 17, 2025 by statnews.com

The FDA has allowed Zyn nicotine pouches to stay on the market, stating that their benefits for adult smokers outweigh the risks. This decision follows a proposal to reduce nicotine in cigarettes to nonaddictive levels. While concerns about youth appeal exist, sales of nicotine pouches have surged. Public health groups are divided, with some fearing increased youth use, while others see harm reduction potential. Zyn's flavored pouches owned by Philip Morris International contain nicotine, although the FDA warns against all tobacco products. Marketing restrictions will be imposed, aiming to target adults over 21. Despite controversy, proponents view this decision as a step towards reducing tobacco-related harm.

January 16, 2025 by cspdailynews.com

FDA granted marketing approval to 20 Zyn nicotine pouch products, making it the first FDA-authorized nicotine pouch. The products offer various flavors and two nicotine strengths. The authorization, obtained by Philip Morris International's acquisition of Zyn maker Swedish Match, prohibits reduced-risk claims. The FDA evaluated public health benefits, with evidence showing reduced harm compared to cigarettes and smokeless tobacco. Marketing restrictions aim to prevent youth access. Despite FDA approval for sale, it doesn't indicate product safety. The FDA closely monitors marketing and youth use. Over 26 million tobacco products have been reviewed, including flavored oral tobacco and smokeless tobacco.

January 16, 2025 by cspdailynews.com

FDA granted marketing approval to 20 Zyn nicotine pouch products, making it the first FDA-authorized nicotine pouch. The products offer various flavors and two nicotine strengths. The authorization, obtained by Philip Morris International's acquisition of Zyn maker Swedish Match, prohibits reduced-risk claims. The FDA evaluated public health benefits, with evidence showing reduced harm compared to cigarettes and smokeless tobacco. Marketing restrictions aim to prevent youth access. Despite FDA approval for sale, it doesn't indicate product safety. The FDA closely monitors marketing and youth use. Over 26 million tobacco products have been reviewed, including flavored oral tobacco and smokeless tobacco.

January 16, 2025 by daily-pouch.com

UVA Health's study on Nicotine Pouch Use Among US Military Personnel has sparked controversy due to exaggerated health claims. The research suggests an increase in pouch use, partly attributed to smoke-free military environments and performance benefits. The focus should be on transitioning from cigarettes, as dual use is prevalent in the army. The skewed demographics in the military lead to higher tobacco use rates. UVA Health's emphasis on pouches is criticized, as cigarettes pose a greater threat. The study's alarmist tone towards pouches overlooks the potential benefits and serves the agenda of anti-tobacco groups.

January 16, 2025 by cnn.com

The FDA proposes reducing nicotine levels in tobacco products to combat addiction and save lives. If enacted, the US would be the first country to implement such a measure. Lower nicotine levels could help millions quit smoking, especially youth who often start smoking and face addiction. The proposal targets cigarettes, cigars, and pipe tobacco but excludes e-cigarettes and other noncombusted products. Despite potential lawsuits from the tobacco industry, the FDA aims to reduce tobacco-related illnesses and healthcare costs. The public can comment on the proposal, which could take years to be finalized and aims to prevent millions of smoking-related deaths and illnesses.

January 16, 2025 by cspdailynews.com

President Biden's administration is proposing a rule to reduce nicotine levels in cigarettes to combat smoking-related diseases, making the US the first to take such action globally. The FDA's proposal aims to cap nicotine at 0.7 milligrams per gram of tobacco in cigarettes and certain products, excluding e-cigarettes and premium cigars. Public feedback is welcomed until September 15. This initiative is part of Biden's Cancer Moonshot plan. Trump's stance on the proposal is uncertain, while in 2019, the FDA postponed a similar plan introduced by former Commissioner Gottlieb. The public can provide comments on various aspects of the proposed rule, with the FDA considering future steps based on the feedback received.

January 16, 2025 by usnews.com

The Biden administration proposes a rule to greatly reduce nicotine in combustible tobacco products, aiming to tackle the public health threat of smoking. The FDA's proposal excludes e-cigarettes and hookahs but advocates praise the potential impact on addiction and health costs. If finalized, the rule would reduce nicotine levels by 96%, aiming to save millions of lives and prevent young people from smoking. The FDA faced challenges in formulating the rule but aims to withstand legal opposition. The future of the rule's finalization depends on the incoming administration.